Industries > Pharma > Pharma Leader Series: Top 50 Pharmaceutical Contract Manufacturing Organisations (CMOs) Market Report 2021

Pharma Leader Series: Top 50 Pharmaceutical Contract Manufacturing Organisations (CMOs) Market Report 2021

In-depth Analysis of Top 50 Pharma CMOs: Capabilities, Results, Competition and Sales Potentials

PUBLISHED: 06 January 2021
PAGES: 395
PRODUCT CODE: PHA1026
SUBMARKET: Contract Services

Clear
WOOCS 2.2.1
SKU: PHA1026 Categories: , Tags: ,

Are you in the global race? Where do you stand in the cut throat global competition?
Fierce competition, stringent regulations, diminishing research and development, shrinking margins, strong price pressures and patent cliffs encompass today’s drug industry. It is a well-known fact that future of the pharmaceutical/biopharmaceutical industry depends on innovation, and innovation comes from collaborations or partnerships.

Buy this report to find out an analysis of strategies adopted by Top 50 players in the market to stay ahead of their competitor.

Contract manufacturing and outsourcing in the form of pay for services or strategic collaboration has resulted in the development of a new paradigm that offers new opportunities to companies for improving their bottom lines through the conversion of fixed costs to variable costs. Contract manufacturers that perform custom synthesis and produce intermediates, active pharmaceutical ingredients and dosage forms are becoming increasingly important for the drug developers to conduct their business more efficiently. Rapid economic growth in the emerging markets is also advancing the pharmaceutical/biopharmaceutical contract manufacturing market. Cost, once considered the only reason for outsourcing, is now accomplished by quality and reliability.

To access the data contained in this document please email contactus@visiongain.com

How this report will benefit you?
The 395-page report provides clear detailed insight into the pharmaceutical contract manufacturing market. Discover the global top 50 rankings, top business strategies adopted by the key players, product mapping, services provided, recent activities of the companies, key drivers and challenges affecting the market.

Read on to discover how you can exploit the future business opportunities emerging in this sector. In this brand new 434-page report you will receive 400+ tables and 300+ figures– all unavailable elsewhere.

Market Insights
Boots Contract Manufacturing, a unit of Wallgreen Boots Alliance Inc., was the leader in the non-sterile liquid contract manufacturing market with a xx% share. Catalent Pharma Solutions had a 6.8% share, and GlaxoSmithKline (GSK) and Perrigo Company PLC also had notable shares in this market. Mylan N.V., Lyne Laboratories and Wockhardt Ltd. are other contributors in the non-sterile liquid dosage form market via contract manufacturing. Many renowned pharmaceutical companies such as Boehringer Ingelheim, AbbVie Inc., Dr. Reddy’s, Pharmaceutical International GmbH and Jubilant Lifesciences also contributed to this market, holding a 69.3% cumulative market share.

COVID-19 Impact on Pharmaceutical Contract Manufacturing Market
Due to the recent outbreak of COVID-19, the changing delivery chain scenario is likely to have a prominent effect in the short term on global contract manufacturing, including China. The demand for large-scale contract manufacturing is expected to increase significantly as pharmaceutical companies start full-scale operations following the coronavirus outbreak. After the end of the COVID-19 pandemic, several organizations will seek to increase their productivity to meet the growing demand. This means that such larger companies should appoint contract development and manufacturing organizations to deal with losses suffered during the crisis. In addition, numerous governmental bodies develop innovative plans to boost contract development and producing organizations to boost productivity for other bigger organizations.

By ordering and reading our brand-new report today you stay better informed and ready to act. Visiongain’s study is intended for anyone requiring commercial analyses for the top 50 pharmaceutical contract manufacturing market. You find data, trends and predictions.

Companies Profiled in the Report
• AbbVie Inc Company
• Aenova Group Company
• Ajinomoto Bio-Pharma Services Company
• Alcami Corporation Company
• Alkermes Biotechnology company
• Almac Group Company
• Aurobindo Pharma Ltd.
• Avid Bioservices Inc.
• Baxter Biopharma Solutions Company
• Bayer AG Company
• Biocon Limited Company
• Biomay AG Company
• Biophore India Pharmaceuticals Private Limited Company
• Bora Pharmaceuticals Company
• C.H. Boehringer Sohn AG & Ko. KG Company
• Cambrex Corporation Company
• Cardinal Health, Inc. Company
• Catalent Pharma Solutions Inc.
• Cepia Sanofi Company (Parental of Sanofi)
• Charles River Laboratories International, Inc. Company
• Consort Medical plc
• Corden Pharma International Company
• Daito Pharmaceutical Co., Ltd. Company
• Delpharm SAS Company
• Divi’s Laboratories Ltd
• DPT Laboratories, Ltd. (Mylan N.V.) Company
• Dr. Reddy’s Laboratories Company
• Evonik Degussa Company
• F. Hoffmann-La Roche Ltd
• Famar S.A. Company
• Fareva Pharmaceuticals Company
• Fujifilm Diosynth Biotechnologies (Merck & co subsidiaries)
• GlaxoSmithKline Pharmaceutical Company
• Huapont Life Sciences Co Ltd Company
• Koninklijke DSM N.V. (Royal DSM) Company
• Lonza AG Company
• Nipro Corporation
• Pfizer Company
• Recipharm AB Company
• SAFC Biosciences (Merck KGaA Subsidiaries) Company
• Samsung Biologics Company
• Siegfried Holding Company
• Strides Pharma Science Limited Company
• Teva Pharmaceuticals Company
• Therapure Biopharma, Inc. Company
• Thermo Fisher Scientific Inc.
• UPM Pharmaceuticals Company
• Vetter Pharma Company
• WuXi AppTec Company
• Zhejiang Hisun Pharmaceutical Company

To access the data contained in this document please email contactus@visiongain.com

Buy our report today Pharma Leader Series: Top 50 Pharmaceutical Contract Manufacturing Organisations (CMOs) Market Report 2021: In-depth Analysis of Top 50 Pharma CMOs: Capabilities, Results, Competition and Sales Potentials. Avoid missing out by staying informed – order our report now.

Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6

Do you have any custom requirements we can help you with? Any need for a specific country, geo region, market segment or specific company information? Contact us today, we can discuss your needs and see how we can help: sara.peerun@visiongain.com

Download sample pages

Complete the form below to download your free sample pages for Pharma Leader Series: Top 50 Pharmaceutical Contract Manufacturing Organisations (CMOs) Market Report 2021


Download sample pages

Complete the form below to download your free sample pages for Pharma Leader Series: Top 50 Pharmaceutical Contract Manufacturing Organisations (CMOs) Market Report 2021


Latest Pharma news

Visiongain Publishes 3D Printing for Healthcare Market Report 2021-2031

The growing use of this technology in many applications such as transplantation, drug delivery, 3D printed organs, and many others in the healthcare industry is one of the key drivers in the global 3D Printing in Healthcare Market.

02 August 2021

READ

Visiongain Publishes Checkpoint Inhibitors for Treating Cancer Market Report 2021-2031

We predict strong revenue growth through to 2031. Our work identifies which organizations hold the greatest potential. Discover their capabilities, progress, and commercial prospects, helping you stay ahead.

29 July 2021

READ

Visiongain Publishes Direct-to-Patient Market Report 2021-2031

Over the last few years, Direct-to-Patient has gained widespread attention. DTP companies offer their customers, who are patients, in this case, all kinds of services.

21 July 2021

READ

Visiongain Publishes Drug Delivery Technologies Market Report 2021-2031

Rising geriatric population, increasing prevalence of chronic and infectious diseases, escalating investment in drug R&D by biopharmaceutical companies, rising demand for advanced drug delivery technologies for chronic treatment are some of the major factors that drive the growth of the global drug delivery technologies market.

20 July 2021

READ

Categories